Article info
Poster Presentations
Cytokines and inflammatory mediators
SAT0019 SDF-1/CXCR4 Is associated with the Disease Activity and Bone and Joint Destruction in Patients with Rheumatoid Arthritis Treated with Golimumab
Citation
SAT0019 SDF-1/CXCR4 Is associated with the Disease Activity and Bone and Joint Destruction in Patients with Rheumatoid Arthritis Treated with Golimumab
Publication history
- First published June 9, 2015.
Online issue publication
April 13, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2015, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions